Skip to content
PodcastsScienceThe Long Run with Luke Timmerman

The Long Run with Luke Timmerman

Timmerman Report
The Long Run with Luke Timmerman
Latest episode

207 episodes

  • The Long Run with Luke Timmerman

    Ep209: Mathai Mammen on Developing Drugs Against Undruggable Targets

    09/09/2026 | 1h 36 mins.
    Mathai Mammen, CEO of Cambridge, Mass.-based Parabilis Medicine, on developing alpha helical peptide molecules against hard targets of disease.
  • The Long Run with Luke Timmerman

    Ep208: Gary Nabel on Developing a Vaccine for Epstein-Barr Virus

    25/08/2026 | 1h 7 mins.
    Gary Nabel, CEO of Weston, Mass.-based ModeX Therapeutics, on developing a vaccine for Epstein-Barr Virus.
  • The Long Run with Luke Timmerman

    Ep207: Jason Coloma on Genetic Medicines for Kidney Diseases

    11/08/2026 | 1h 17 mins.
    Jason Coloma, CEO of South San Francisco-based Maze Therapeutics, on developing small molecule drugs based on human genetics for kidney diseases.
  • The Long Run with Luke Timmerman

    Ep206: Lyn Baranowski on Inhalable Medicines for Severe Lung Diseases

    28/07/2026 | 1h 7 mins.
    Lyn Baranowski, CEO of Boston-based Avalyn Pharma, on developing inhalable medicines for severe lung diseases.
  • The Long Run with Luke Timmerman

    Ep205: Heather Turner on a Schizophrenia Drug Patients Can Stick With

    14/07/2026 | 1h 8 mins.
    Heather Turner, CEO of New York-based LB Pharma, on developing a new schizophrenia drug designed to better cross the blood-brain barrier, be dosed once daily, and make it easier for patients to take long term.
More Science podcasts
About The Long Run with Luke Timmerman
"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
Podcast website

Listen to The Long Run with Luke Timmerman, The Great Simplification with Nate Hagens and many other podcasts from around the world with the radio.net app

Get the free radio.net app

  • Stations and podcasts to bookmark
  • Stream via Wi-Fi or Bluetooth
  • Supports Carplay & Android Auto
  • Many other app features